AAAAAA

   
Results: 1-10 |
Results: 10
A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ET-743, A NOVEL MINOR-GROOVE BINDER OF MARINE ORIGIN ADMINISTERED ON A DAILY X 5 SCHEDULE
Authors: HIDALGO M VILLALONACALERO MA ECKHARDT SG WEISS G CAMPBELL E KRAYNAK M BEIJNEN J JIMENO J VONHOFF D ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ET-743, A NOVEL MINOR-GROOVE BINDER OF MARINE ORIGIN ADMINISTERED ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 613-613
PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS
Authors: BOWMAN A TWELVES C HOEKMAN K SIMPSON A SMYTH J VERMORKEN J HOPPENER F BEIJNEN J VEGA E JIMENO J HANAUSKE AR
Citation: A. Bowman et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS, Annals of oncology, 9, 1998, pp. 452-452
A PHASE-I AND PHARMACOKINETIC STUDY OF ET-743, A NOVEL DNA MINOR-GROOVE BINDER OF MARINE ORIGIN, ADMINISTERED AS A 1-HOUR INFUSION DAILY X 5 DAYS
Authors: VILLALONACALERO M ECKHARDT SG WEISS G CAMPBELL E HIDALGO M KRAYNAK M BEIJNEN J JIMENO J VONHOFF D ROWINSKY E
Citation: M. Villalonacalero et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ET-743, A NOVEL DNA MINOR-GROOVE BINDER OF MARINE ORIGIN, ADMINISTERED AS A 1-HOUR INFUSION DAILY X 5 DAYS, Annals of oncology, 9, 1998, pp. 453-453
PHASE-I AND PHARMACOKINETIC STUDY OF ECTEINASCIDIN-743 (ET-743) GIVENAS A ONE-HOUR INFUSION EVERY 21 DAYS
Authors: TWELVES CJ VERMORKEN J BOWMAN A SIMPSON A SMYTH J HOPPENER F BEIJNEN J JIMENO J HANAUSKE AR
Citation: Cj. Twelves et al., PHASE-I AND PHARMACOKINETIC STUDY OF ECTEINASCIDIN-743 (ET-743) GIVENAS A ONE-HOUR INFUSION EVERY 21 DAYS, European journal of cancer, 33, 1997, pp. 1107-1107
SUCCESSFUL INTRAPERITONEAL SURAMIN TREATMENT OF PERITONEAL MESOTHELIOMA
Authors: WESTERMANN AM DUBBELMAN R MOOLENAAR WH BEIJNEN J RODENHUIS S
Citation: Am. Westermann et al., SUCCESSFUL INTRAPERITONEAL SURAMIN TREATMENT OF PERITONEAL MESOTHELIOMA, Annals of oncology, 8(8), 1997, pp. 801-802
CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH ADVANCED OVARIAN-CANCER -A DOSE-FINDING STUDY
Authors: HUININK WT VEENHOF C HUIZING M RODENHUIS S HELMERHORST T DUBBELMAN R DALESIO O BEIJNEN J WINOGRAD B
Citation: Wt. Huinink et al., CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH ADVANCED OVARIAN-CANCER -A DOSE-FINDING STUDY, Seminars in oncology, 24(1), 1997, pp. 31-33
SUBSTITUTION OF DIDANOSINE SACHETS BY CHEWABLE TABLETS - A PHARMACOKINETIC STUDY IN PATIENTS WITH AIDS
Authors: BURGER D MEENHORST P MULDER J HENRICHS J FRISSEN J KROON F TENNAPEL C KOKS K BULT A BEIJNEN J
Citation: D. Burger et al., SUBSTITUTION OF DIDANOSINE SACHETS BY CHEWABLE TABLETS - A PHARMACOKINETIC STUDY IN PATIENTS WITH AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 163-168
ROLE OF GLUTATHIONE IN THE EXPORT OF COMPOUNDS FROM CELLS BY THE MULTIDRUG-RESISTANCE-ASSOCIATED PROTEIN
Authors: ZAMAN GJR LANKELMA J VANTELLINGEN O BEIJNEN J DEKKER H PAULUSMA C OUDEELFERINK RPJ BAAS F BORST P
Citation: Gjr. Zaman et al., ROLE OF GLUTATHIONE IN THE EXPORT OF COMPOUNDS FROM CELLS BY THE MULTIDRUG-RESISTANCE-ASSOCIATED PROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(17), 1995, pp. 7690-7694
PRELIMINARY-RESULTS OF 2 DOSE-FINDING STUDIES OF PACLITAXEL (TAXOL) AND CARBOPLATIN IN NONSMALL CELL LUNG AND OVARIAN CANCERS - A EUROPEAN-CANCER-CENTER EFFORT
Authors: GIACCONE G HUIZING M HUININK WT KOOLEN M POSTMUS P VANKRALINGEN K VANZANDWIJK N VERMORKEN J BEIJNEN J DALESIO O PINEDO H VEENHOF C
Citation: G. Giaccone et al., PRELIMINARY-RESULTS OF 2 DOSE-FINDING STUDIES OF PACLITAXEL (TAXOL) AND CARBOPLATIN IN NONSMALL CELL LUNG AND OVARIAN CANCERS - A EUROPEAN-CANCER-CENTER EFFORT, Seminars in oncology, 21(5), 1994, pp. 34-38
PHASE-I AND PHARMACOKINETICS STUDY OF TOPOTECAN, A NEW TOPOISOMERASE-I INHIBITOR
Authors: VERWEIJ J LUND B BEIJNEN J PLANTING A DEBOERDENNERT M KOIER I ROSING H HANSEN H
Citation: J. Verweij et al., PHASE-I AND PHARMACOKINETICS STUDY OF TOPOTECAN, A NEW TOPOISOMERASE-I INHIBITOR, Annals of oncology, 4(8), 1993, pp. 673-678
Risultati: 1-10 |